No profile data available.
Becton, Dickinson and Company (BDX) is a healthcare company in the various healthcare equipment manufacturing industry, based in Franklin Lakes, United States, with about 72,000 full-time employees.
It reported revenue of $21.84 billion for fiscal year 2025, up 8.2% from fiscal year 2024, and net income of $1.68 billion. In Q3 2026 (the quarter ended June 30, 2026) revenue was $4.98 billion. Its largest business segment, BD Medical, brought in 52% of segment revenue in fiscal year 2025; United States was the largest region with 59%. Its market capitalization was $50.05 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended September 30, 2025; market data as of October 9, 2026.
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.
Becton, Dickinson and reported $21.84 billion in revenue for fiscal year 2025, up 8.2% from $20.18 billion in fiscal year 2024. In Q3 2026 revenue was $4.98 billion.
BD Medical, with $11.46 billion or 52% of segment revenue in fiscal year 2025. Next: BD Interventional (24%) and BD Life Sciences (24%).
United States: 59% of revenue by region in fiscal year 2025, followed by Europe, The Middle East and Africa (22%).
$50.05 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (various healthcare equipment manufacturing) include Medtronic plc (MDT), Stryker Corporation (SYK), Boston Scientific Corporation (BSX), Koninklijke Philips N.v. (PHG).